Gut microbiome composition may influence GLP-1 production, though evidence in humans remains preliminary
Secondo i dati di Surmount-5, tirzepatide ha portato in media a una riduzione del peso corporeo del -20,2%, rispetto al -13,7% ottenuto con semaglutide
In rodent secretagogue studies, this combined blend has been investigated for its complementary action on GHRH and GHS-R1a receptors and the resulting pulsatile growth-hormone release
As compared with nonobese HFpEF, patients with obesity-related HFpEF display distinct pathophysiologic features, including greater volume expansion 5,17 , more severe inflammation 6,7 , increases in visceral and paracardiac adipose tissue 5,15,18,19 and more severe myocardial injury 15
Additionally, genetic ancestry was further refined through genotype clustering analyses using reference populations from the 1000 Genomes Project